Filing Details

Accession Number:
0000711377-10-000021
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-04 20:57:24
Reporting Period:
2010-10-01
Filing Date:
2010-10-04
Accepted Time:
2010-10-04 20:57:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189003 R Richard Current Vice President & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-10-01 443 $9.02 47,237 No 4 M Direct
Common Stock Disposition 2010-10-01 443 $32.97 46,794 No 4 S Direct
Common Stock Acquisiton 2010-10-01 2,124 $13.55 48,918 No 4 M Direct
Common Stock Disposition 2010-10-01 2,124 $32.97 46,794 No 4 S Direct
Common Stock Acquisiton 2010-10-01 15,924 $13.55 62,718 No 4 M Direct
Common Stock Disposition 2010-10-01 15,924 $32.97 46,794 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Options (Right to buy) Disposition 2010-10-01 443 $9.02 443 $9.02
Common Stock Common Stock Option (Right to buy) Disposition 2010-10-01 2,124 $13.55 2,124 $13.55
Common Stock Common Stock Option (Right to buy) Disposition 2010-10-01 15,924 $13.55 15,924 $13.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
49,463 2011-11-03 No 4 M Direct
47,339 2012-08-09 No 4 M Direct
31,415 2012-08-09 No 4 M Direct
Footnotes
  1. The options were granted 11/3/06 as ISO options and became vested 20% yearly thereafter.
  2. The options were granted 8/9/07 as ISO options and became vested 20% yearly thereafter